Kibow® Biotech’s “Enteric Dialysis®” Technology and Its Renadyl™ Product Formulation for Maintaining Healthy Kidney Function Is to Showcase Its Ultimate Validation at the Annual ASN 2017 – Kidney Week Conference

Source: Newtown Square, PA

Kibow® Biotech is proud to announce its twentieth year of operations as a leader in the kidney health supplement marketplace. For the past 13 years, Kibow® has been participating and exhibiting at the annual meeting of the American Society of Nephrology: Kidney Week event (https://www.asn-online.org/kidneyweek/) educating nephrology professionals on the crucial role of the gut-kidney connection, dysbiosis, and modulation of the Gut Microbiome with its innovative “Enteric Dialysis®” technology. Although marketed and sold in USA/Canada as a dietary supplement product, Renadyl™ is the first and only kidney health supplement formulated and developed with a pharmaceutical like validation, which utilizes revolutionary “Enteric Dialysis®” technology.

Read More →


20 Year Old Kibow® Biotech Further Validates Enteric Dialysis® Concept, With Greater Understanding of Modulating the Gut Microbiome with Pro/Prebiotics Towards Maintaining Healthy Kidney Function

Source: Newtown Square, PA

One of the world’s prominent meetings in nephrology, the ISN World Congress of Nephrology is being held in Mexico City, Mexico from April 21st-25th (https://www.wcn2017.org/). Kibow® Biotech Inc. has been participating at this bi-annual event since 2005 held successively in Singapore, Hong Kong, Milan, Rio De Janerio, Vancouver, Cape Town, and this year in Mexico City. Concurrently, Kibow® Biotech Inc. is also attending the NKF Spring Clinical Meeting in Orlando, Florida (https://www.kidney.org/spring-clinical). Kibow® Biotech will be an exhibitor at both of the events, putting its revolutionary concept of Enteric Dialysis® on display. Throughout Kibow®’s 20 years of operations, the company has gained an industry-leading understanding of modulating the gut microbiome to maintain healthy kidney function.

Read More →


Kibow® Biotech Inc. to Support the World Kidney Day (March 9th) With an Independent Educational Webinar on “Obesity and Chronic Kidney Disease”

Source: Newtown Square, PA

Kibow® Biotech Inc. to Support the World Kidney Day (March 9th) With an Independent Educational Webinar on “Obesity and Chronic Kidney Disease” and Modulating the “Gut Microbiome With Pro/Prebiotics” Based on Its Novel “Enteric Dialysis®” Technology Formulation

Read More →


Kibow® Biotech Inc: A new initiative is launched to mark World Kidney Day 2016

Source: Newtown Square, PA

The Lancet and the International Society of Nephrology (ISN) are launching an online campaign to raise awareness of acute and chronic kidney diseases and bring together the best available evidence to inform strategies to reduce the national, regional and global burden of the disease and its risk factors. Chronic kidney disease affects 10% of the population worldwide and that number is growing.

Read More →


Kibow® Biotech Inc: To support World Kidney Day with its innovative “Enteric Dialysis” technology

Source: Newtown Square, PA

Kibow® Biotech Inc is pleased to support World Kidney Day with its innovative “Enteric Dialysis” technology in Modulating the “Gut Microbiome with Pro/Prebiotics” using its dietary supplement product “Renadyl”;

Newtown Square, PA – March 13: “World Kidney Day is a global awareness campaign aimed at raising awareness on the importance of our kidneys. World Kidney Day aims to raise awareness of the importance of our kidneys to our overall health and to reduce the frequency and impact of kidney disease and its associated health problems worldwide.

Read More →


Kidney Health: Reducing Risk and Raising Awareness

Source: Chicago Tribune

“Kidney Health: Reducing Risk and Raising Awareness” in collaboration with the National Kidney Foundation, is the largest kidney related report of the year distributed within the Chicago Tribune on August 19th in a full distribution of 540,000 copies. Kidney health is a major issue affecting tens of millions of people. Although the two main causes of kidney disease are diabetes and high blood pressure, there are many other conditions and lifestyle choices that directly affect the kidney’s well-being.

Read More →


 Global upswing for probiotic and prebiotic food and beverages

Source: nutraingredients-usa.com

World sales of probiotic and prebiotic foods and beverages climbed 12.5 percent to reach about $15.4bn in 2008 compared with the year before, according to research group Packaged Facts.

                                                                                                                                                                 Read More →